Wittström, Elisabeth <br/><br/>
Clinical and electrophysiologic outcome in patients with neovascular glaucoma treated with and without bevacizumab.  [electronic resource] 

 -  European journal of ophthalmology   
 - 563-74 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1724-6016 
<br/><br/><label>Standard No.: </label>10.5301/ejo.5000089  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Angiogenesis Inhibitors--administration & dosage<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Bevacizumab<br/>Combined Modality Therapy<br/>Electrophysiology<br/>Electroretinography<br/>Female<br/>Glaucoma, Neovascular--drug therapy<br/>Humans<br/>Intravitreal Injections<br/>Laser Coagulation<br/>Male<br/>Photoreceptor Cells, Vertebrate--physiology<br/>Prospective Studies<br/>Retina--physiopathology<br/>Retinal Vein Occlusion--drug therapy<br/>Treatment Outcome<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors<br/>Visual Acuity--physiology